HEIDELBERG, Germany & VIENNA, May 27, 2025--(BUSINESS WIRE)--RHEACELL, a German biotech company specialized in the development of stem cell therapies, and AOP Health, a Europe-based leader in ...
AOP Health US, LLC today announced that the first patient in the United States has been treated with Rapiblyk® (landiolol) at ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
VIENNA--(BUSINESS WIRE)--AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
VIENNA--(BUSINESS WIRE)--AOP Health announced new results on ropeginterferon alfa-2b (BESREMi®) from its clinical study CONTINUATION-PV in patients with polycythaemia vera (PV), a rare blood cancer.
International biopharma specializing in rare diseases and critical care connects R&D, quality, commercial, and data on the Veeva Vault Platform to accelerate innovation "AOP Health's mission is to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results